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Abstract 
 
Purpose:  To establish the medium-term repeatability of the iPad perimetry app Melbourne 
Rapid Fields (MRF) compared to Humphrey Field Analyzer (HFA) 24-2 SITA-standard and 
SITA-fast programs.   
Design: Multicentre longitudinal observational clinical study. 
Participants: 60 patients (stable glaucoma/ocular hypertension/glaucoma suspects) were 
recruited into a 6-month longitudinal clinical study with visits planned at baseline, 2-, 4- and 
6-months. 
Methods: At each visit patients undertook visual field assessment using the MRF perimetry 
application and either HFA SITA-fast (n=21) or SITA-standard (n=39).   
Main outcome measures: The primary measure was the association and repeatability of 
mean defect (MD) for the MRF and HFA tests. Secondary measures were the point-wise 
threshold and repeatability for each test as well as test time. 
Results: MRF was similar to SITA-fast in speed and significantly faster than SITA-standard 
(MRF 4.6±0.1 mins vs. SITA-fast 4.3±0.2 mins vs. SITA-standard 6.2±0.1 mins, P<0.001).  
Intra-class correlation coefficients (ICC) between MRF and SITA-fast for Mean Deviation 
(MD) at the four visits ranged from 0.71 to 0.88. ICC values between MRF and SITA-standard 
for MD ranged from 0.81 to 0.90. Repeatability of MRF MD outcomes was excellent, with 
ICC for baseline and the 6-month visit being 0.98 [95%: 0.96-0.99]. In comparison, ICC at 6-
month retest for SITA-fast was 0.95 and SITA-standard 0.93. Fewer points changed with the 
MRF although for those that did, the MRF gave greater point-wise variability than did the 
SITA tests.  
Conclusions: MRF correlated strongly with HFA across 4 visits over a 6-month period, and 
has good test-retest reliability. MRF is suitable for monitoring visual fields in settings where 
conventional perimetry is not readily accessible.  
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Abstract 
 
Purpose:  To establish the medium-term repeatability of the iPad perimetry app Melbourne 
Rapid Fields (MRF) compared to Humphrey Field Analyzer (HFA) 24-2 SITA-standard and 
SITA-fast programs.   
Design: Multicentre longitudinal observational clinical study. 
Participants: 60 patients (stable glaucoma/ocular hypertension/glaucoma suspects) were 
recruited into a 6-month longitudinal clinical study with visits planned at baseline, 2-, 4- and 
6-months. 
Methods: At each visit patients undertook visual field assessment using the MRF perimetry 
application and either HFA SITA-fast (n=21) or SITA-standard (n=39).   
Main outcome measures: The primary measure was the association and repeatability of 
mean defect (MD) for the MRF and HFA tests. Secondary measures were the point-wise 
threshold and repeatability for each test as well as test time. 
Results: MRF was similar to SITA-fast in speed and significantly faster than SITA-standard 
(MRF 4.6±0.1 mins vs. SITA-fast 4.3±0.2 mins vs. SITA-standard 6.2±0.1 mins, P<0.001).  
Intra-class correlation coefficients (ICC) between MRF and SITA-fast for Mean Deviation 
(MD) at the four visits ranged from 0.71 to 0.88. ICC values between MRF and SITA-standard 
for MD ranged from 0.81 to 0.90. Repeatability of MRF MD outcomes was excellent, with 
ICC for baseline and the 6-month visit being 0.98 [95%: 0.96-0.99]. In comparison, ICC at 6-
month retest for SITA-fast was 0.95 and SITA-standard 0.93. Fewer points changed with the 
MRF although for those that did, the MRF gave greater point-wise variability than did the 
SITA tests.  
Conclusions: MRF correlated strongly with HFA across 4 visits over a 6-month period, and 
has good test-retest reliability. MRF is suitable for monitoring visual fields in settings where 
conventional perimetry is not readily accessible.  
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Introduction 
The Humphrey Field Analyser (HFA) is the clinical standard for reliable and 
reproducible visual field outcomes in patients with glaucoma 1, however the cost of the 
device and its lack of portability limit its accessibility to patients from impoverished places  
and those in rural and remote locations. There are some who have used hardcopy charts, 
tablets, virtual reality goggles and other devices as portable visual field screeners or 
threshold devices 2-7. In comparison, the Melbourne Rapid Fields (MRF) is an iPad tablet 
application (iPad3 or later) that allows in office or remote visual field testing due to its low 
cost and portability. MRF has been shown to produce comparable results to the HFA and 
have good intra-session test-retest repeatability 8,9,however, the longer-term repeatability 
of this device is unknown.  Detection of visual field progression in glaucoma depends on 
frequency of testing and variability of the visual field testing procedure 10,11, therefore, 
knowing the longer-term repeatability of the device is important in determining whether 
MRF is suitable for clinical use. 
The MRF has been validated as a tangent perimeter which can perform efficient and 
reliable thresholding comparable to HFA 24-2 SITA-standard protocol9. It has been shown to 
be robust to variations in ambient light, blur and viewing distance 8. When retest was 
undertaken after a 5-minute break in 78 cases with glaucoma (intrasession test-retest 
repeatability), patients classified as mild (MD ≥ -6 dB, n=41) gave a coefficient of 
repeatability (std. dev./mean) of 7.8% for their MD whereas 37 cases with moderate to 
severe defect (MD < -6 dB) returned a coefficient of repeatability of 24.2% in their MD9.  
Retest variability for the Medmont M700 automated perimeter has been reported as 2.9 dB 
(11.6%), whereas abnormal locations have a larger coefficient of repeatability (33%; SD ~8.0 
dB)8.Hence, test-retest repeatability depends upon the threshold of the location, and for the 
MRF, it appears comparable to that reported for other perimeters 8,12. 
Despite the similarity to the literature and high intra-test repeatability, it is not 
known whether this good performance of the MRF will be returned over longer retest 
periods.  This is because the MRF differs from the HFA in many ways 8 and it is not clear how 
these differences may impact on long term reliability. The main differences in the MRF rests 
in test spot location, test spot size (which increases into the periphery) and its thresholding 
logic. Threshold variability is known to increase with eccentricity in normals 13. As the MRF 
spot size increases in the periphery of MRF test patterns8 it could be expected that the MRF 
will have reduced variability due to the larger spot sizes13. Another factor to influence 
variability is the MRF thresholding logic which is achieved using a3-step Bayes predictor8,14. 
Although similar procedures have been shown to return reliable outcomes with 6 to 12 
steps14,15 it is not clear that this will hold for a 3-step prediction. In particular, it is not 
apparent how this approach will compare to the SITA algorithms which utilise a post-hoc 
Bayes prediction returned from 4/2dB (SITA-standard) or 4dB step (SITA-fast) procedures.  
Given these differences in test logic, the repeatability of both the MRF and HFA are 
in need of comparison especially when applied in a review schedule common to clinical 
settings. This 6-month longitudinal study was undertaken to investigate the medium-term 
repeatability of the MRF compared to that found for HFA SITA-fast and SITA-standard 
outcomes derived from a common cohort of patients who undertook repeated testing on 
these devices. 
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Method 
The clinical trials reported in this manuscript were undertaken with approval of the local 
ethics committees (Integrated Research Application System IRAS ID: 204698: West of 
Scotland Research Ethics Service REC No: 16/WS/0130: and AIIMS IEC-564/03.11.2017) and 
were conducted in accordance with the tenets of the Declaration of Helsinki with all 
subjects giving informed consent prior to participation. This clinical trial has been registered 
as ISRCTN77744218 at https://doi.org/10.1186/ISRCTN77744218. 
 
Melbourne Rapid Fields app 
The MRF app (GLANCE Optical Pty Ltd, Melbourne, Australia) produces efficient and 
reliable thresholds using an iPad (Apple, Cupertino, CA) tablet device viewed at 33 cm with 
the patient wearing their normal reading glasses. The radial test pattern comprises 66 test 
locations (Figure 1) with more details of the test procedures found elsewhere8,9. The 9.7-
inch iPad subtends 30° x 24° (H x V) at a viewing distance of 33 cm (13 inches: eccentricity 
15° x 12° with central fixation).  Regions having greater eccentricity than 15° x 12° can be 
tested by having the patient shift fixation to one of the four corners of the iPad, allowing 
one quadrant 30° x 24° (H x V) to be tested at a time. Voice commands generated by the 
tablet instruct the patient on how to perform the test and when to alter fixation during the 
test to permit evaluation of the peripheral visual field.  Apart from the need to alter fixation, 
some of the other procedural or test differences in the application have been detailed 
before 8,9. Our previous study found that despite these differences the MRF returns 
outcomes that were strongly correlated to HFA thresholds 9and the purpose of this study is 
to consider whether medium-term variability is similar to that of the HFA. 
 
Figure 1 about here 
 
Participants 
Sixty patients were recruited at two clinical sites (Table 1) namely: Cambridge UK (n 
= 39, age: 37–89, mean: 70.1) and New Delhi, India (n = 21, age: 15–59, mean: 35.3). Study 
participants had either: stable ocular hypertension (n = 3: IOP>21 mmHg with normal VF and 
optic nerve), stable treated glaucoma (n = 51: optic nerve and/or VF changes consistent with 
glaucoma and diagnosis confirmed by fellowship trained glaucoma subspecialists), or are 
glaucoma suspects (n = 6:IOP<=21, with subtle changes in optic nerve and/or VF that do not 
meet definitive diagnosis of glaucoma). Patients were asked to return every 2-months 
during a 6-month cycle of normal reviews (3 follow up visits). Table 1 shows that 25 
participants (42%) had a mild visual field defect (HFA MD ≥ -6dB), 20(33%) exhibited a 
moderate loss (HFA MD -6 to -12dB) and 15 (25%) exhibited an advanced loss (HFA MD < -
12dB). Exclusion criteria were: the presence of a systemic condition or use of systemic drugs 
that could affect vision, a need to change glaucoma medications or undergo eye surgery 
over the review period or in the preceding 6-months, inability to understand or comply with 
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the English voice commands of the MRF, visual acuity worse than 6/12 (20/40) and, poor 
reliability indices on HFA at baseline (FL >30%, FP >15%, FN >20%).  
 
Table 1 about here 
 
Testing Procedures 
Study participants were recruited at baseline, being one of their normal review 
dates, and were requested to come again at 2-, 4-, and 6-months; the 6-month visit was part 
of their review schedule. At each visit, they performed the MRF and either 24-2 SITA-fast or 
SITA-standard (but not both, see Table 1) on the worse eye having the lower Mean Defect 
on HFA. At baseline, patients performed HFA first followed by MRF to determine if they met 
inclusion criteria. The order of the tests was randomised at subsequent visits. Not all 
patients complied with the scheduled 2-monthly visits and attendance rates for the 
respective time points are listed in Table 2 (range 70-97%).The average interval between 
tests was 2.6-months. 
MRF testing was performed using a 9.7-inch iPad generation 3 tablet (Apple, Cupertino, 
CA) in a dimly lit room with screen brightness automatically adjusted to maximal hardware 
brightness by the app at the start of the testing procedure. The iPad was turned on for a 
minimum of 10 minutes prior to testing to allow for stability of luminous output. 
 
Table 2 about here 
 
Data Analysis 
 Elsewhere we have found the correlation between MRF MD and HFA SITA-standard 
MD values follow a linear relationship (MDHFA = 1.25 * MDMRF – 0.51)
9.  In the present study 
we have corrected the raw MD values from MRF using this relationship without altering the 
raw dB thresholds. Later when we analyse the variability in the pointwise data, this analysis 
has been derived from the raw values and not the scaled data. 
To allow comparison of point-wise retinal thresholds, all left eye data were reflected 
in the vertical to produce equivalent right eye fields. Correlation analysis was conducted 
using a Deming regression that allows for error in both the x- and y-axes. For this study, we 
performed two analyses: one that included repeated testing on individuals and the other 
derived from the average outcome for individual patients over multiple time points (average 
of at least 3 tests). All data are shown as mean ±SEM unless stated otherwise. 
 Bland-Altman analysis quantified bias (average difference) and the 95% limits of 
agreement (LoA) by comparing baseline to the 6-month test. A coefficient of 
repeatability(CoR %) was determined as the standard deviation of the Bland-Altman 
difference data divided by the mean threshold11.To quantify the accuracy of the tests we 
adopted Lin’s Coefficient of Accuracy (Ca) which indicates concordance between two tests 
measuring a common attribute16. Other coefficients (eg. Pearson) consider association 
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between data to a line of any slope whereas the Coefficient of Accuracy determines the 
degree to which pairs of observations derived from two continuous variables fall on the 
diagonal line that passes through the origin; perfect concordance to the diagonal is a Ca of 
1.0.Ca values between 0.65 and 0.79 indicate ‘moderate’ concordance, between 0.8 and 
0.89‘substantial’ concordance and between 0.9 and 1.0 indicate ‘almost perfect’ 
concordance16.We have also calculated the Intra-class correlation (ICC) for our data, as this 
is a commonly used statistic for such comparisons. ICCs and many other statistics were 
calculated using Microsoft Excel for Windows (Microsoft, Redmond, WA, USA) spreadsheets. 
As the mean defect statistic (MD) is a global measure it may act to mask changes at a 
local or regional level, so we consider repeatability in the 8 regions defined in Figure 1 as 
well as on a point-wise basis. 
Group comparisons were performed using a repeated measure analysis of variance 
(ANOVA) and t-tests were used to identify significant departures when the ANOVA indicated 
a significant main effect. An alpha of 0.05 was used for all analysis.  
 
Results 
Figure 2 shows representative field results for two patients measured with the MRF 
and HFA SITA-standard test. The left panels are MRF outcomes for a patient having mild 
(Figure 2, upper-left) and moderate (Figure 2, lower-left) visual field loss whereas the right 
panels show the corresponding HFA outcomes for the same patients with key statistics 
indicated beside each panel. 
 
Figure 2 about here 
 
The average test times for MRF, SITA-fast and SITA-standard are shown in Figure 3. 
The MRF required 4.6 ± 0.1 mins (mean ± SEM) for testing which is significantly faster than 
the average for SITA-standard,6.2 ± 0.1 mins (p<0.001) but marginally slower than SITA-fast, 
4.3 ± 0.2mins (p=0.05, Figure 3). 
 
Figure 3 about here 
 
Figure 4 and Table 3 show the concordance between the corrected MD of the MRF 
and SITA-fast and SITA-standard outcomes. Figure 4 shows the data averaged over all time 
points whereas Table 3 lists these outcomes for each retest period. As can be seen from the 
regression lines of Figure 4, the data show strong associations for MRF and SITA-standard 
and SITA-fast (dashed and solid lines in Figure 4) with the average Coefficient of Accuracy 
being substantial (0.83) between MRF and SITA-standard and moderate (0.77) between 
MRF and SITA-fast.  This concordance in the average MD statistic is further evidenced in 
Table 3 where moderate to substantial Coefficients of Accuracy are returned between the 
MRF MDs and those of the HFA tests. The negative bias (-1.2 to -3.4 dB) present at all time 
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points in Table 3 indicates that on average the MRF returns marginally smaller MDs than 
does the HFA although the average difference (-1.32 dB) may not be clinically significant.   
 
Figure 4 about here 
 
Table 3 about here 
 
One important consideration from a clinic context, is how the tests perform between 
two successive visits for the same patient. For this analysis we compare MRF and SITA 
outcomes as a difference from baseline and at 6-months for each patient. This comparison 
is shown as Bland-Altman plots in Figure 6 and the strength of association at retest is listed 
in Table 4. Figure 6 shows that the corrected MRF values have little bias and a similar level 
of test-retest repeatability as both the HFA SITA-fast or SITA-standard tests (Table 4). 
Overall, the concordance in MRF outcomes between baseline and the 6-month visit are 
almost perfect (Ca=0.95; ICC =0.98, Table 4) and was greater than either version of SITA test 
(p<0.05, Table 4). The average bias for both versions of SITA at retest is significantly 
removed from zero (SITA-standard: 0.8 dB, SITA-fast: 1.0, p<0.05) indicating a small 
improvement or ‘learning effect’. The MRF shows lower variability in its MD at retest, as 
evident by the 95% LoA in Table 4 (4.0 vs 5.6, SITA-standard, p=0.19and 7.5, SITA-fast, 
p=0.04). These return a better Coefficient of Repeatability for MRF (8.1%) compared with 
SITA-fast (17.9%, p=0.001) or SITA-standard (12.2%, p=0.02). 
 
Table 4 about here 
 
Given that the global MD of the MRF compares well to the equivalent index in both 
SITA tests, this does not mean that the tests have concordance on a regional or point-wise 
basis. Figure 5 considers the point-wise retest variability across the three tests as a function 
of average threshold. These data were pooled and binned across all observers to yield 
Figure 5, left panel, which shows that variability increases with a decrease in threshold, 
peaking at about 8 dB for the HFA tests over a threshold range of 10-20 dB. The peak for the 
MRF was about 10 dB (average 35% greater) over a similar threshold range. Of note, SITA-
fast is marginally more variable compared to SITA-standard at intermediate threshold values 
(14-22 dB) consistent with a similar observation made by Saunders et al17. 
These point-wise findings expose a paradox, in that, how do we reconcile the better 
global performance of MRF (Table 4) given this 35% greater variability? The answer lies in 
Figure 5, right panel, which shows that majority of points (~60%) do not change at retest 
with the MRF (0-3.9 dB standard deviation) compared with 10% for the HFA (both SITA tests 
were similar). The outcomes in Figure 5 indicate that the 3-step Bayes used by the MRF 
returns more stable outcomes than either SITA logic, but that when thresholds change, they 
do so with greater variability. This likely arises from the larger ‘steps’ used by the 3-step 
procedure. Figure 5, left-panel, also indicates that large changes are more likely at 
intermediate threshold values. 
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Figure 5 about here 
 
Figure 6 about here 
 
Given that the point-wise analysis for the MRF shows more stability yet greater 
variability in outcomes, we consider whether the regional analysis defined in Figure 1 does 
likewise. Table 5 shows that the MRF returns similar thresholds to the HFA tests in all zones 
with Coefficient of Accuracy (Ca) ranging from 0.61 to 0.92. Of note, the best Ca’s are found 
in the arcuate/nasal step zones (MRF vs SITA-fast 0.76 to 0.90: MRF vs SITA-standard 0.81 to 
0.92) which are areas more commonly affected by glaucoma. However, the central zones 1, 
2 yield moderate Ca’s (0.61 to 0.74) which might reflect the lower number of points that the 
HFA grid has in this region. Indeed, the positive bias in Table 5 indicates that the MRF has 
lower thresholds (up to 2.7dB) in these locations, implying that its more densely arranged 
grid might be detecting early macula defects in some glaucoma patients.  
 
Table 5 about here 
 
Discussion 
In this study, we demonstrate that, over a 6-month period, the MRF provides a 
reliable and repeatable estimate of HFA MD (SITA-standard and SITA-fast) within a test time 
that approximates that of the SITA-fast logic. This is despite: the greater number of test 
spots (with more spots in the macular region), the different test spot locations, the variable 
size of the spot, the different procedures used to determine threshold and the need for 
fixation changes during the test. We find the test time of the MRF is some 0.3 min/eye 
slower than is SITA-fast but approximately 1.6 min/eye faster than SITA-standard when 
testing is conducted on the 9.7-inch iPad. In a separate and unpublished study, test times 
were derived from 28 patients for the large screen (12.9-inch) iPad Pro and found a 1.2 ±0.8 
mins shorter test time than with for the standard 9.7-inch screen version (data not shown). 
The faster time arises from the fewer fixational movements needed with the 12.9-inch 
screen which means tests will be about 1 minute/eye faster than SITA-fast. Faster test times 
are important where there is limited time and resources available to care for large patient 
loads and they also facilitate home monitoring by patients. 
The corrected MRF MD provides a reliable estimate of HFA MD returned from both 
the SITA-standard and SITA-fast testing procedures (Figure 4). Moreover, the MRF shows 
similar or better repeatability (Figures 6) in the MD than do either HFA procedures. We find 
the coefficient of repeatability (CoR) for MD to be 17.9% for SITA-fast, 12.2% for SITA-
standard and 8.1% for MRF. For the MRF, this CoR was similar to the 7.8% reported 
elsewhere for patients having mild defects [3] and is significantly smaller than the CoR 
returned for both HFA tests. The retest variability found for the SITA tests in this study is 
similar to that reported for the Medmont perimeter (11.6%) 12 although past work has 
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noted that this can increase substantially in areas of scotoma;  therefore the CoR value 
returned for any study will in part, reflect the severity of visual field defects in those 
patients included in that study. For that reason, we do not believe that the absolute level of 
variability should be considered in such comparisons but rather the relative level for both 
HFA tests should be compared to the MRF, as these were obtained from a common cohort 
of patients tested at the same visit. This comparison indicates that the MRF has about 30-
50% less variability in the global index MD than does either HFA test protocol.  
In what appears to be a paradox, we find that the quantisation used by the 3-step 
test strategy leads to greater stability in most test points but larger variability on a point-
wise basis when change occurs (Figure 5). This finding implies that the test might be limited 
in detecting early progression especially in regions having some loss of threshold already 
(10-22 dB) as it will require a larger change in order to be found by the MRF. This possibility 
has not been supported by recent simulation which finds frequent retesting  (weekly or 
monthly) will minimise this effect11.   
In conclusion, we find that the MRF provides a reliable and repeatable index of visual 
field defect comparable to that seen with HFA in either SITA-standard or SITA-fast test 
modes. It does so in about the same time as it takes for a SITA-fast test using a standard 
iPad (9.7-inch) screen.  Together with the portability and relative low cost of tablet devices, 
tablet-based visual field tests have great potential in the delivery of quality vision care for 
glaucoma patients in situations where access to standard perimetry machines is difficult (eg. 
in rural/remote locations, developing countries, indigent outreach, domiciliary service etc.). 
The fact that the MRF compares well to the HFA for the detection of glaucoma has been 
confirmed by an independent clinical trial where correlations similar to those found in this 
manuscript have been reported18. 
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Figure Legends 
 
Figure 1. Location of test spots for the MRF (left, 66 spots) and HFA (right, 54 spots) and 
definition of eight zones used for regional analysis. The grey zone includes the blind spot and 
was excluded from analysis. All results are considered as right eye equivalent.  
 
Figure 2. Representative visual field outcomes in two eyes having mild (upper- left and 
upper-right) and moderate (lower-left and lower-right) visual field defects. MRF outcomes 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
11 
 
are shown in A and C.  HFA SITA-standard thresholds and total deviation plots are shown in 
Band D. Note, all normal locations for the MRF return 30 dB. 
 
Figure 3. Box plots of test time for SITA-fast (n=73), MRF (n=212) and SITA-standard (n=139) 
across all visits. Whiskers identify the maximum and minimum values. 
 
Figure 4. Association between the HFA MD and the corrected MRF MD averaged over all 
tests that the patient attended. Unfilled circles (dotted line) show SITA-fast data and filled 
circles (solid line) show SITA-standard. Regression lines are: SITA-fast, y = 0.92±0.11*x - 
3.4±1.0: SITA-standard: y = 1.00±0.07*x - 1.6±0.5.  
 
Figure 5. Point-wise variability of HFA and MRF over the entire trial in observers who 
undertook 3 or more retests. Left panel. Point-wise standard deviation (dB) plotted against 
average threshold (dB). Black circles show SITA-fast, grey circles indicate MRF outcomes, and 
unfilled circles represent SITA-standard. Right panel. The relative number of points that 
return the standard deviation (dB) on the x-axis for both HFA (black bars) and MRF (grey 
bars) tests. 
 
Figure 6. Bland-Altman plot of outcomes comparing the MD of MRF and HFA at baseline and 
6 months. Left panel. SITA-Fast vs MRF-Radial (n = 17). Right panel. SITA-standard vs MRF (n 
= 34). Black filled circles are SITA-fast, and grey filled circles are MRF and unfilled circles are 
SITA-standard. Solid horizontal line is the bias and dotted lines show 95% Limits of 
Agreement for HFA. 
 
Table Legends 
 
Table 1. Patient demographics for groups recruited at the 2 sites.  Patients at the Cambridge 
site performed MRF and SITA-standard whereas those at the India site performed MRF and 
SITA-fast. POAG: Primary open angle glaucoma. JOAG: Juvenile open angle glaucoma. OHT: 
Ocular hypertension. Other Glaucoma includes: Psuedoexfoliative glaucoma (1), Normal 
tension glaucoma (4), Neovascular glaucoma (1), Primary angle closure glaucoma (2) 
Inflammatory glaucoma (1). 
 
Table 2. Patient compliance for testing at baseline, 2-, 4- and 6-month review periods. 
Figures in brackets indicate numbers (or %) who attended in Cambridge and India, 
respectively. 
 
Table 3. Comparison of MD for SITA-fast vs MRF and SITA-standard vs MRF at each time 
point. Negative values indicate lower average MD values on the HFA. Ca: coefficient of 
accuracy (0.65<Ca<0.79, moderate; 0.8<Ca<0.89, substantial; 0.9<Ca<1.0, almost perfect). 
ICC: Intra-class coefficient. 95% CI: 95% confidence interval for ICC. Bland-Altman, Bias and 
95% LoA: 95% limits of agreement for retest data.  
 
Table 4. Correlation statistics for baseline vs next visit for the MRF, SITA-fast and SITA-
standard. Ca: Lin’s concordance coefficient (0.8<Ca<0.89, substantial; 0.9<Ca<1.0, almost 
perfect). ICC: Intra-class coefficient. 95% CI: 95% confidence interval for ICC. Bland-Altman, 
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Bias and 95% LoA: 95% limits of agreement for retest data. * significantly removed from 
zero, p<0.05.  
 
Table 5. Average zone threshold for SITA-fast vs MRF and SITA-standard vs MRF. Negative 
values indicate lower average zone thresholds on the HFA in that region. Ca: Lim’s 
concordance coefficient (0.8<Ca<0.9; substantial; 0.9<Ca<1.0, almost perfect). ICC: Intra-
class coefficient. 95% CI: 95% confidence interval for ICC. Bland-Altman, Bias and 95% LoA: 
95% limits of agreement for retest data.  
 
 
 
Table 1 
  Cambridge India All 
Test Subjects  39 21 60 
Age [min-max]  70.1 [37-89] 35.3 [15-59] 57.9 [15-89] 
Gender % Female 51 14 38 
Diagnosis Glaucoma Suspect 6 0 6 
 POAG 22 2 24 
 JOAG 0 18 18 
 OHT 3 0 3 
 Other Glaucoma 8 1 9 
HFA Protocol SITA-standard 34 1 35 
 SITA-fast 5 20 25 
Severity (HFA MD) Mild (≥ -6 dB) 20 5 25 
 Moderate (-6 to -12 dB) 11 9 20 
 Severe (< -12 dB) 8 7 15 
     
 
 
 
    
Table 1. Patient demographics for groups recruited at the 2 sites.  Patients at the Cambridge 
site performed MRF and SITA-standard whereas those at the India site performed MRF and 
SITA-fast. POAG: Primary open angle glaucoma. JOAG: Juvenile open angle glaucoma. OHT: 
Ocular hypertension. Other Glaucoma includes: Psuedoexfoliative glaucoma (1), Normal 
tension glaucoma (4), Neovascular glaucoma (1), Primary angle closure glaucoma (2) 
Inflammatory glaucoma (1). 
 
Table 1
Table 2 
 Baseline 2-months 4-months 6-months 
No. of patients 60 (39, 21) 52 (33, 19) 42 (28,14) 58 (39, 19) 
% Compliance 100 87 (85, 90) 70 (72, 67) 97 (100, 90) 
 
 
 
Table 2. Patient compliance for testing at baseline, 2-, 4- and 6-month review periods. 
Figures in brackets indicate numbers (or %) who attended in Cambridge and India, 
respectively. 
 
Table 2
Table 3 
 SITA-fast vs MRF across all visits, MD comparison  
Zone Ca ICC (95% CI) Bias, dB 95% LoA, dB  
Baseline 0.67 0.71 (0.53, 0.83) -2.9 -5.5, -0.5  
2-months 0.78 0.82 (0.68, 0.89) -3.4 -4.6, -2.2  
4-months 0.81 0.88 (0.78, 0.92) -3.1 -4.7, -1.5  
6-months 0.82 0.87 (0.77, 0.92) -2.9 -4.5, -1.3  
       
  
 
     
 SITA-standard vs MRF across all visit, MD comparison 
Zone Ca ICC (95% CI) Bias, dB 95% LoA, dB 
Baseline 0.79 0.81 (0.67, 0.89) -2.2 -3.2, -1.3 
2-months 0.85 0.88 (0.78, 0.93) -1.3 -2.1, -0.4 
4-months 0.86 0.90 (0.82, 0.94) -1.2 -2.0, -0.4 
6-months 0.83 0.86 (0.74, 0.91) -1.9 -2.7, -1.1 
 
 
 
Table 3. Comparison of MD for SITA-fast vs MRF and SITA-standard vs MRF at each time 
point. Negative values indicate lower average MD values on the HFA.  
 
Ca: coefficient of accuracy (0.65<Ca<0.79, moderate; 0.8<Ca<0.89, substantial; 0.9<Ca<1.0, 
almost perfect). ICC: Intra-class coefficient. 95% CI: 95% confidence interval for ICC. Bland-
Altman, Bias and 95% LoA: 95% limits of agreement for retest data.  
 
Table 3
Table 4 
 Baseline vs 6-monthvisit, MD 
 n Ca ICC (95% CI) Bias, dB 95% LoA, dB 
SITA-fast 18 0.89 0.95 (0.91, 0.97) 1.0* -2.7, 4.8 
SITA-standard 35 0.90 0.93 (0.87, 0.96) 0.8* -2.0, 3.6 
MRF 50 0.95 0.98 (0.96, 0.99) 0.0 -2.0, 2.0 
 
 
 
Table 4. Correlation statistics for baseline vs next visit for the MRF, SITA-fast and SITA-
standard.  
 
Ca: Lin’s concordance coefficient (0.8<Ca<0.89, substantial; 0.9<Ca<1.0, almost perfect). ICC: 
Intra-class coefficient. 95% CI: 95% confidence interval for ICC. Bland-Altman, Bias and 95% 
LoA: 95% limits of agreement for retest data. * significantly removed from zero, p<0.05.  
 
 
 
Table 4
1 
 
Table 5 
 SITA-fast vs MRF mean zone threshold  
Zone Ca ICC (95% CI) Bias, dB 95% LoA, dB  
1 0.61 0.62 (0.40, 0.78) 2.7 1.3, 4.2  
2 0.65 0.67 (0.47, 0.81) 1.3 0.2, 2.4  
3 0.79 0.82 (0.70, 0.90) 1.0 -0.6, 2.6  
4 0.88 0.91 (0.84, 0.95) 0.6 -0.7, 2.0  
5 0.90 0.92 (0.86, 0.96) -0.3 -1.6, 1.1  
6 0.76 0.80 (0.66, 0.88) 0.1 -2.0, 2.1  
7 0.80 0.83 (0.70, 0.90) -0.3 -2.0, 1.3  
8 0.83 0.86 (0.76, 0.92) 1.3 0.0, 2.5  
       
 SITA-standard vs MRF mean zone threshold 
Zone Ca ICC (95% CI) Bias, dB 95% LoA, dB 
1 0.74 0.78 (0.62, 0.87) 0.0 -1.8, 1.8 
2 0.67 0.68 (0.48, 0.81) 2.3 1.4, 3.2 
3 0.88 0.91 (0.85, 0.95) 0.7 -0.5, 1.9 
4 0.92 0.95 (0.92, 0.97) 1.0 0.1, 2.0 
5 0.85 0.88 (0.80, 0.93) -0.7 -2.1, 0.8 
6 0.83 0.86 (0.76, 0.92) -0.1 -1.3, 1.0 
7 0.81 0.84 (0.73, 0.91) 1.2 0.0, 2.3 
8 0.84 0.87 (0.77, 0.92) 2.1 1.1, 3.1 
 
 
Table 5. Average zone threshold for SITA-fast vs MRF and SITA-standard vs MRF. Negative 
values indicate lower average zone thresholds on the HFA in that region.  
 
Ca: Lim’s concordance coefficient (0.8<Ca<0.9; substantial; 0.9<Ca<1.0, almost perfect). ICC: 
Intra-class coefficient. 95% CI: 95% confidence interval for ICC. Bland-Altman, Bias and 95% 
LoA: 95% limits of agreement for retest data.  
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In this multicentre longitudinal study we establish the medium-term repeatability of an iPad 
perimetry app Melbourne Rapid Fields (MRF) and compare this to the Humphrey Field 
Analyzer (HFA) 24-2 SITA-standard and SITA-fast programs.  MRF was similar to SITA-fast in 
test speed. MRF correlated strongly with HFA across 4 visits over a 6-month period and has 
good test-retest reliability. MRF is suitable for monitoring visual fields in settings where 
conventional perimetry is not readily accessible.  
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